Variant report
Variant | nsv526931 |
---|---|
Chromosome Location | chr8:8765165-8766881 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10097779 | chr8:8765165-8765166 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs191892599 | chr8:8765174-8765175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs574991703 | chr8:8765270-8765271 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs28514965 | chr8:8765285-8765286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540791523 | chr8:8765315-8765316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560710853 | chr8:8765349-8765350 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183665954 | chr8:8765387-8765388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs28655065 | chr8:8765438-8765439 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562328563 | chr8:8765523-8765524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531303148 | chr8:8765532-8765533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs57226640 | chr8:8765536-8765537 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs544853351 | chr8:8765543-8765544 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs140719191 | chr8:8765546-8765547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs533650604 | chr8:8765562-8765563 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188369695 | chr8:8765602-8765603 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570357343 | chr8:8765606-8765607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539330070 | chr8:8765607-8765608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181770162 | chr8:8765634-8765635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs28698801 | chr8:8765635-8765636 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs185720954 | chr8:8765648-8765649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190542006 | chr8:8765654-8765655 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112723800 | chr8:8765685-8765686 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186873358 | chr8:8765686-8765687 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs34085398 | chr8:8765689-8765690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540779498 | chr8:8765705-8765706 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541338995 | chr8:8765780-8765781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536666315 | chr8:8765784-8765785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560648127 | chr8:8765793-8765794 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs560075055 | chr8:8765796-8765797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577401815 | chr8:8765798-8765799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546097556 | chr8:8765809-8765810 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563169536 | chr8:8765813-8765814 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557065229 | chr8:8765821-8765822 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs34803132 | chr8:8765843-8765844 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs529242124 | chr8:8765848-8765849 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549013592 | chr8:8765849-8765850 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs562621170 | chr8:8765861-8765862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs59890653 | chr8:8765899-8765900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531869677 | chr8:8765900-8765901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547742180 | chr8:8765926-8765927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs190034897 | chr8:8765943-8765944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs17642782 | chr8:8765951-8765952 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs12543940 | chr8:8765994-8765995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570294672 | chr8:8766004-8766005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs17154924 | chr8:8766047-8766048 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs144617653 | chr8:8766202-8766203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569894117 | chr8:8766223-8766224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs375774935 | chr8:8766244-8766245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147861307 | chr8:8766265-8766266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs542659752 | chr8:8766282-8766283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Developmental disorder | 20461109 | CNVD |
abnormal development | 18461090 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastric cancer | 17229543 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:8751600-8775000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr8:8752800-8775000 | Weak transcription | Primary T cells effector/memory enriched fromperipheralblood | blood |
3 | chr8:8758600-8775000 | Weak transcription | Small Intestine | intestine |
4 | chr8:8759200-8770200 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr8:8759200-8770200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr8:8762400-8766000 | Weak transcription | Fetal Stomach | stomach |
7 | chr8:8762400-8769400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
8 | chr8:8762400-8770800 | Weak transcription | HUVEC | blood vessel |
9 | chr8:8763000-8770600 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr8:8763200-8783200 | Weak transcription | Pancreas | Pancrea |
11 | chr8:8765400-8766400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr8:8765800-8766400 | Enhancers | Stomach Mucosa | stomach |
13 | chr8:8766000-8766200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr8:8766000-8766200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr8:8766000-8766400 | Enhancers | Fetal Kidney | kidney |
16 | chr8:8766000-8766400 | Enhancers | Fetal Stomach | stomach |
17 | chr8:8766200-8769400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
18 | chr8:8766400-8769400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
19 | chr8:8766400-8775000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |